Ana Antun, MD, MSc

One star
One star
One star
One star
One half star

Rating: 4.6 out of 5 (54 ratings)

Role

Hematology
Specialty

Blood Disorders
Research Program

Cancer Prevention and Control
Practicing Since

2010

Call 404-778-1900

Background

Ana Antun, MD, MSc, is an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Antun is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute.

Dr. Antun earned her medical degree at the National University of Cordoba in Cordoba, Argentina. She then went onto complete her internship and residency at Albert Einstein College of Medicine in Bronx, New York. In 2010, Dr. Antun completed her fellowship from Emory University School of Medicine in Atlanta, Georgia.

Titles & Roles

Associate Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine
Section Co-Chief, Hematology and Medical Oncology

Atlanta Veterans Affairs Medical Center

Education & Training

Education

Fellowship, Hematology & Oncology, 2010
Emory University School of Medicine
Residency, Internal Medicine, 2007
Albert Einstein College of Medicine of Yeshiva University
Medical Education, MD, 1995
National University of Cordoba-Argentina

Board Certifications

Hematology
American Board of Internal Medicine, 2010
Internal Medicine
American Board of Internal Medicine, 2007

Professional Memberships

American Society of Hematology
International Society of Thrombosis and Hemostasis
World Federation of Hemophilis
Pulmonary Embolism Response Team Consortium
Association of VA Hematology/Oncology
United State Thrombotic Microangiopathy Consortium

Research

Publications

Title/Journal	Authors	Publication Date
Global patterns of hemophilia drug trials, hemophilia care, and health care measures. Research and practice in thrombosis and haemostasis	SA Fedewa, LA Valentino, A Koo, L Cafuir, TW Gillespie, TW Buckner, DQ Tran, A Antun, CL Kempton	02/01/2025
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era. Blood advances	A Fatola, MD Evans, J Brown, E Davis, A Johnson, AG Antun, AM Farland, R Woods, A Metjian, YA Park, G de Ridder, B Gibson, RS Kasthuri, DK Liles, S Eubanks, F Akwaa, T Clover, LB Kreuziger, JE Sadler, M Sridharan, RS Go, KR McCrae, HV Upreti, MY Lim, NK Kocher, R Gangaraju, XL Zheng, JS Raval, C Masias, SR Cataland, M Mazepa, S Chaturvedi	01/28/2025
Women and girls' participation in haemophilia clinical trials. Haemophilia : the official journal of the World Federation of Hemophilia	SA Fedewa, L Cafuir, LA Valentino, A Koo, A Antun, CL Kempton	11/01/2024
Racial and Ethnic Differences in Distress, Depression, and Quality of Life in people with hemophilia. Journal of racial and ethnic health disparities	SA Fedewa, TW Buckner, SG Parks, DQ Tran, L Cafuir, AG Antun, S Mattis, CL Kempton	06/01/2024
Race and ethnicity reporting and representation in hemophilia clinical trials. Blood advances	SA Fedewa, LA Valentino, A Koo, L Cafuir, DQ Tran, A Antun, CL Kempton	05/28/2024
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura. The New England journal of medicine	M Scully, A Antun, SR Cataland, P Coppo, C Dossier, N Biebuyck, WA Hassenpflug, K Kentouche, P Knöbl, JA Kremer Hovinga, MF López-Fernández, M Matsumoto, TL Ortel, J Windyga, I Bhattacharya, M Cronin, H Li, B Mellgård, M Patel, P Patwari, S Xiao, P Zhang, LT Wang	05/02/2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura. Research and practice in thrombosis and haemostasis	MY Abou-Ismail, C Zhang, AP Presson, S Chaturvedi, AG Antun, AM Farland, R Woods, A Metjian, YA Park, G de Ridder, B Gibson, RS Kasthuri, DK Liles, F Akwaa, T Clover, LB Kreuziger, M Sridharan, RS Go, KR McCrae, HV Upreti, R Gangaraju, NK Kocher, XL Zheng, JS Raval, C Masias, SR Cataland, AD Johnson, E Davis, MD Evans, M Mazepa, MY Lim	03/01/2024
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry. Blood advances	MY Abou-Ismail, C Zhang, AP Presson, S Chaturvedi, AG Antun, AM Farland, R Woods, A Metjian, YA Park, G de Ridder, B Gibson, RS Kasthuri, DK Liles, F Akwaa, T Clover, L Baumann Kreuziger, M Sridharan, RS Go, KR McCrae, HV Upreti, R Gangaraju, NK Kocher, XL Zheng, JS Raval, C Masias, SR Cataland, AD Johnson, E Davis, MD Evans, M Mazepa, MY Lim	02/13/2024
Racial and ethnic differences in reported haemophilia death rates in the United States. Haemophilia : the official journal of the World Federation of Hemophilia	SA Fedewa, AB Payne, D Tran, L Cafuir, A Antun, CL Kempton	11/01/2023
Race, rituximab, and relapse in TTP. Blood	S Chaturvedi, AG Antun, AM Farland, R Woods, A Metjian, YA Park, G de Ridder, B Gibson, RS Kasthuri, DK Liles, F Akwaa, T Clover, L Baumann Kreuziger, JE Sadler, M Sridharan, RS Go, KR McCrae, HV Upreti, A Liu, MY Lim, R Gangaraju, XL Zheng, JS Raval, C Masias, SR Cataland, A Johnson, E Davis, MD Evans, MA Mazepa	09/22/2022
How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge. Blood	F Akwaa, A Antun, SR Cataland	08/04/2022
Longitudinal Changes in Hematologic Parameters Among Transgender People Receiving Hormone Therapy. Journal of the Endocrine Society	A Antun, Q Zhang, S Bhasin, A Bradlyn, WD Flanders, D Getahun, TL Lash, R Nash, D Roblin, MJ Silverberg, V Tangpricha, S Vupputuri, M Goodman	11/01/2020
Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood advances	MA Carden, M Gaddh, A Hoskote, M Brown, V Merrill, SR Stowell, S Chandrakasan, A Antun, R Kudchadkar, S Kotanchiyev, DL Jaye, I Bodó	02/11/2020
The effect of psychological distress on health outcomes: A systematic review and meta-analysis of prospective studies. Journal of health psychology	V Barry, ME Stout, ME Lynch, S Mattis, DQ Tran, A Antun, MJ Ribeiro, SF Stein, CL Kempton	02/01/2020
Exploring changes in distress among individuals with bleeding disorders: What is linked to improvements in distress? Journal of health psychology	V Barry, ME Lynch, DQ Tran, A Antun, A DeBalsi, D Hicks, F Lasseter, S Mattis, MJ Ribeiro, SF Stein, CL Kempton	10/01/2019
Adjuvant low-dose rituximab and plasma exchange for acquired TTP. Blood	JI Zwicker, J Muia, L Dolatshahi, LA Westfield, P Nieters, A Rodrigues, A Hamdan, AG Antun, A Metjian, JE Sadler	09/26/2019
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Hosoba, EK Waller, N Shenvi, M Graiser, KA Easley, Z Al-Kadhimi, A Andoh, AG Antun, S Barclay, CD Josephson, JL Koff, HJ Khoury, AA Langston, JC Zimring, JD Roback, CR Giver	05/01/2018
Paraneoplastic Thrombocytopenia Cured With Nephrectomy and Vena Cava Thrombectomy: Concurrent Hematology and Oncology Management Conundrums. Journal of oncology practice	KR Melnick, C Chang, A Antun, SK Maithel, VA Master	11/01/2017
Physician trust and depression influence adherence to factor replacement: a single-centre cross-sectional study. Haemophilia : the official journal of the World Federation of Hemophilia	DQ Tran, V Barry, A Antun, M Ribeiro, S Stein, CL Kempton	01/01/2017
Expecting the Unexpected. Journal of oncology practice	A Antun, CL Kempton	06/01/2016
The role of disease severity in influencing body mass index in people with haemophilia: a single-institutional cross-sectional study. Haemophilia : the official journal of the World Federation of Hemophilia	M McNamara, A Antun, CL Kempton	03/01/2014
Venous access catheter-related thrombosis in patients with cancer. Leukemia & lymphoma	M Gaddh, A Antun, K Yamada, P Gupta, H Tran, F El Rassi, HS Kim, HJ Khoury	03/01/2014
Bone density in haemophilia: a single institutional cross-sectional study. Haemophilia : the official journal of the World Federation of Hemophilia	CL Kempton, A Antun, DM Antoniucci, W Carpenter, M Ribeiro, S Stein, L Slovensky, L Elon	01/01/2014
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. Cancer	AG Antun, S Gleason, M Arellano, AA Langston, ML McLemore, M Gaddh, F el Rassi, L Bernal-Mizrachi, J Galipeau, LT Heffner, EF Winton, HJ Khoury	11/01/2013
Physical activity and functional abilities in adult males with haemophilia: a cross-sectional survey from a single US haemophilia treatment centre. Haemophilia : the official journal of the World Federation of Hemophilia	J Baumgardner, L Elon, A Antun, S Stein, M Ribeiro, L Slovensky, CL Kempton	07/01/2013
Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis? Chest	A Zhou, A Winkler, A Emamifar, B Gartland, A Duncan, A Antun, M Arellano, GA Tindol, JH Levy, WA Bornstein, IR Horowitz, HJ Khoury	11/01/2012

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.7	One star One star One star One star One half star	Provider showed concern
4.8	One star One star One star One star One half star	Provider explained things clearly
4.7	One star One star One star One star One half star	Provider discussed treatment options
4.7	One star One star One star One star One half star	Provider included you in decisions
4.7	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	04/01/2025	She's wonderful
One star One star Empty star Empty star Empty star	03/10/2025	Dr. Antun, does not have the best bed side manners. I feel at times she does not listen to me I tell her my symptoms are progressing and I'm feeling worse and she will not take that into consideration. She would be like your blood work came back fine so I don't know why and that's all I get. But since I didn't get all the test results back come to find out I had a relapse and even with that I don't seem to see much effort on her part to take action. I'm sure she more focused on the data and I do appreciate that but I would love for her to understand that that's only half of it because the patient knows their body better than anything and if I am saying something is not right believe me. You don't have to await for results to believe. That's all!
One star One star One star One star One star	02/26/2025	I thought the doctor was wonderful. Very thorough
One star One star One star One star One star	02/04/2025	Excellent excellent care
One star One star One star One star One star	12/26/2024	Had no concerns once Dr. Antun & I finished the video appointment.
One star One star One star One star One star	11/12/2024	They asked me if I had any questions twice. It made me feel comfortable.
One star One star One star One star One star	10/22/2024	Dr Autun is a excellent hematologist.
One star One star One star One star One star	06/11/2024	Great Doctor (Dr. Ana Antun)